Haploid Allogeneic Transplant Using the CliniMACS System
Trial ID or NCT#
To assess the proportion of patients with donor neutrophil engraftment within 30 days of allogeneic transplant. To assess the incidence of acute GvHD during the first 100 days after transplantation.
A Feasibility Study Evaluating Haploidentical Allogeneic Transplantation Using the CliniMACS System in Patients With Advanced Hematologic Malignancies
Contact us to find out if this trial is right for you.
View on ClinicalTrials.gov